Selecting Amlenetug: Targeting α-Synucleinopathies Rationally
In the relentless pursuit of therapies to combat neurodegenerative diseases, a transformative breakthrough has emerged with the rational design and ...
In the relentless pursuit of therapies to combat neurodegenerative diseases, a transformative breakthrough has emerged with the rational design and ...
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine